Pure Global

Intrathecal Versus Intravenous Tramadol in prevention of Post-spinal anaesthesia Shivering - Trial PACTR202007664590852

Access comprehensive clinical trial information for PACTR202007664590852 through Pure Global AI's free database. This Not Applicable trial is sponsored by Suez Canal University Hospitals and is currently Completed. The study focuses on Anaesthesia.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
PACTR202007664590852
Not Applicable
Completed
Trial Details
Pan Africa Clinical Trials Registry โ€ข PACTR202007664590852
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intrathecal Versus Intravenous Tramadol in prevention of Post-spinal anaesthesia Shivering

Study Focus

Anaesthesia

Sponsor & Location

Suez Canal University Hospitals

self funded

Egypt

Timeline & Enrollment

Not Applicable

Aug 09, 2020

Jan 06, 2021

Summary

Spinal anesthesia (SA) is a very common technique used by anesthesiologist (1). It involves the injection of a local anaethetic into the subarachnoid space to anaesthetize the lower part of the body. Shivering is a common complication following SA. The incidence varies from 40% to 70%.[1] It is a spontaneous, involuntary and oscillatory fasciculations, or tremor-like hyperactivity of the skeletal muscles.[2] This makes it distressing for both the patient and the surgeon. It increases metabolic rate, oxygen consumption, CO2 production, heart rate, and blood pressure.[1,2] These increase the cardiac workload leading to wound pain, delay wound healing, and prolong hospital stay. It also interferes with the perioperative vital monitoring and increases intraocular and intracranial pressures.[1] All these sequelae coupled with the high incidence of postopearative shivering makes its prophylaxis imperative.Prophylaxis with intravenous (IV) tramadol produces a dose-dependent reduction in the incidence of postanesthesia shivering.[3] Tramadol is a commonly used intrathecal (IT) adjuvant. It prolongs the duration of sensory and motor block, and improves postoperative analgesia.Few studies assess antishivering efficacy of IT tramadol .[2] So the present study aims to compare the antishivering effect of both routes of tramadol (IT and IV) in patients undergoing lower limb orthopedic surgeries under SA. references:1. De Witte J, et al. Perioperative shivering:Physiology and pharmacology.Anesthesiology.2002;96:467โ€“84 2. Prasad RB, et al. Effectiveness of addition of intrathecal tramadol with hyperbaric bupivacaine in prevention of shivering in parturients undergoing caesarean section under spinal anaesthesia: A randomized placebo-controlled study. Karnataka Anaesth J. 2015;1:123โ€“7. 3. Mohta M, et al. Tramadol for prevention of postanaesthetic shivering: A randomised double-blind comparison with pethidine. Anaesthesia. 2009;64:141โ€“6.

ICD-10 Classifications

Anaesthetic, unspecified
Other and unspecified general anaesthetics
Other complications of anaesthesia
Local anaesthetics
Anaesthesia of skin

Data Source

Pan Africa Clinical Trials Registry

PACTR202007664590852

Non-Device Trial